0001193125-26-174417.txt : 20260423 0001193125-26-174417.hdr.sgml : 20260423 20260423210229 ACCESSION NUMBER: 0001193125-26-174417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260421 FILED AS OF DATE: 20260423 DATE AS OF CHANGE: 20260423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TABUTEAU HERRIOT CENTRAL INDEX KEY: 0001219927 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 26890201 MAIL ADDRESS: STREET 1: C/O AXSOME THERAPEUTICS, INC. STREET 2: ONE WORLD TRADE CENTER, 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 ownership.xml 4 X0609 4 2026-04-21 0001579428 Axsome Therapeutics, Inc. AXSM 0001219927 TABUTEAU HERRIOT false C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007 true true true false Chief Executive Officer false Performance Stock Units 2026-04-21 4 A false 24081 0 A Common Stock 24081 24081 D Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock. Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date. /s/ Herriot Tabuteau, M.D. 2026-04-23